A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...

Among patients with Hodgkin lymphoma, the ORR and CR were ... were selected from the MD Anderson Cancer Center Cord Blood Bank and chosen based on the criteria previously identified for optimal ...

Uday R. Popat, MD, discusses promising findings from a phase 2 trial evaluating the JAK inhibitor itacitinib combined with ...

Researchers at MD Anderson Cancer Center at the University of Texas ... Results from an early-stage safety trial in B-cell lymphoma have not shown any incidence of cytokine release syndrome ...

Researchers examined the use and dosing of opioids at the outpatient palliative care clinic of the University of Texas MD Anderson Cancer Center from September 2016 to August 2021. Data on opioids ...